NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
12/10/2019
Back to search
Official data from USPTO
NAL PHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
12/10/2019
Trademark type
Combined
Nice classes
42
Filing date
10/24/2008
Registration date
11/24/2009
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/10/2019
Last transaction
12/10/2019
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
01/07/2008
First use in commerce
01/24/2008
Drawing code
3
Owner type
99
Owner location
HONG KONG, HK
Examiner
I, DAVID
Law office
M50
Current location
GENERIC WEB UPDATE
Mark description
The mark consists of an illustration of an atomic model on the left separated by vertical line with the words "NAL" over the word "PHARMA" to the right of the vertical line.
Holders and representatives
Holders
NAL PHARMACEUTICAL GROUP LIMITED
NAL Pharma Ltd
Representatives
JESS M. COLLEN COLLEN IP, INTELLECTUAL PROPERTY LAW, P.C.
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Research and development of pharmaceutical preparations for use in pain controlarthritismigraineoncologyurologyasthmachronic obstructive pulmonary disease (COPD)cardiovascular diseasesnauseavomitingwound healing and pharmaceutical eye products for the treatment of ocular irritationdry eyeallergy and glaucoma
Publications
History of USPTO decisions and trademark events.
25 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
12/10/2019
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
12/10/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/10/2019
E89R
TEAS SECTION 8 & 9 RECEIVED
10/25/2019
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
11/24/2018
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
04/13/2016
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
12/17/2015
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
12/17/2015
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/17/2015
E815
TEAS SECTION 8 & 15 RECEIVED
10/23/2015
R.PR
REGISTERED-PRINCIPAL REGISTER
11/24/2009
PUBO
PUBLISHED FOR OPPOSITION
09/08/2009
NPUB
NOTICE OF PUBLICATION
08/19/2009
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
08/06/2009
ALIE
ASSIGNED TO LIE
08/06/2009
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/29/2009
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/28/2009
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/28/2009
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/28/2009
CPRA
PRIORITY ACTION MAILED
01/28/2009
CPRA
PRIORITY ACTION WRITTEN
01/27/2009
DOCK
ASSIGNED TO EXAMINER
01/27/2009
MDSM
NOTICE OF DESIGN SEARCH CODE MAILED
10/29/2008
NWAP
NEW APPLICATION ENTERED
10/28/2008
Continuous trademark protection
Get notified about every new filing that threatens NAL PHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.